Valuation
- Market cap
- 4,347,000
- Revenue TTM
- $12,250,000
- Net income TTM
- $160,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 1.31%
- Debt to equity
- 0.00
Trading
- Volume
- 4,700
- Avg volume
- 154,374
- Day's range
- $3.22 – $3.29
- Shares out
- 1,350,000
- Stochastic %K
- 0%
- Beta
- 0.73
- Analysts
- —
- Price target
- $12.00
Company profile
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular...
Show more
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 800 873 5141
- Website
- https://www.guardionhealth.com
- Address
- 2925 Richmond Avenue, Suite 1200, Houston, United States
Latest news
No headlines yet.
